There were no significant differences in VCAM-1 and ICAM-1, biomarkers associated with cardiovascular disease risk40, but due to the younger age of the study population, this observation should be analyzed carefully as Lyytinen et al.17 revealed potential cardiovascular risk of HTP use. This evidence concerns the gene ICAM1 and cardiovascular disorder.